SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030102
Filing Date
2019-08-07
Accepted
2019-08-07 16:22:00
Documents
74
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnst-10q_20190630.htm 10-Q 2617550
2 EX-10.1 cnst-ex101_29.htm EX-10.1 63311
3 EX-31.1 cnst-ex311_9.htm EX-31.1 9610
4 EX-31.2 cnst-ex312_8.htm EX-31.2 9583
5 EX-32.1 cnst-ex321_7.htm EX-32.1 5677
6 EX-32.2 cnst-ex322_6.htm EX-32.2 5757
7 GRAPHIC gopeihskg3py000001.jpg GRAPHIC 40735
  Complete submission text file 0001564590-19-030102.txt   7531356

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cnst-20190630.xml EX-101.INS 1485309
9 XBRL TAXONOMY EXTENSION SCHEMA cnst-20190630.xsd EX-101.SCH 48977
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20190630_cal.xml EX-101.CAL 49176
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20190630_def.xml EX-101.DEF 131714
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20190630_lab.xml EX-101.LAB 370542
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20190630_pre.xml EX-101.PRE 280372
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 191005808
SIC: 2834 Pharmaceutical Preparations